ENTITY

Melinta Therapeutics (MLNT US)

Analysis

Health Care • United States

Melinta Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops antibiotics for the treatment of infectious diseases such as respiratory tract and skin structure infections. Melinta Therapeutics offers its services in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00